RNA viruses pose significant challenges to public health due to their high mutation rates and diverse mechanisms of infection which allow them to rapidly adapt to new hosts and evade therapeutic ...

So, researchers at Northwestern started their journey to figure out why this might be happening. They discovered when someone ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...

Shares of biopharma companies levered to COVID-19 vaccines tumbled on Thursday after President-elect Donald Trump picked ...

From the moment DeSantis appointed Florida Surgeon General Joseph Ladapo in 2021, it was clear that Ladapo had little ...

On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch ...

Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.